Related by context. Frequent words. (Click for all words.) 68 pathogen inactivation 61 INTERCEPT Blood System 57 Neuradiab 54 hESC lines 53 hematopoietic cell 53 allogeneic stem cell 53 pharmacodynamic effects 52 BLA submission 52 PLX cells 52 allogeneic 52 pharmacokinetic studies 52 Urocidin 52 liposomal formulation 52 pharmacokinetic PK 52 romiplostim 52 HSCT 52 noninferiority 51 Marrow Transplantation 51 surrogate endpoint 51 NSABP 51 Octapharma 51 therapeutic regimens 50 phase IIa 50 efficacy endpoint 50 cells hESCs 50 liver transplant recipients 50 preclinical toxicology 50 efficacy endpoints 50 maribavir 50 deforolimus 50 omecamtiv mecarbil 50 HERmark 50 cryopreserved 50 liprotamase 50 AABB 50 NGAL 49 eniluracil 49 ISTODAX 49 Phase IIa trial 49 BNC# 49 hGH CTP 49 serologic 49 biphasic 49 relapsed multiple myeloma 49 secondary efficacy endpoints 49 IGIV 49 QRxPharma 49 PLX PAD 49 coagulation factors 49 irbesartan 49 ZLB Behring 49 hematopoietic cells 49 immunohistochemical 49 Secondary endpoints include 48 LVAS 48 Azedra 48 SWOG 48 apheresis 48 achieved statistical significance 48 MOZOBIL 48 hematopoietic 48 Swissmedic 48 bone marrow stem cell 48 Phase Ib clinical 48 IND submission 48 PROPEL trial 48 VIAject 48 azacitidine 48 autologous 48 atacicept 48 Platelet 48 tipranavir 48 von Willebrand factor 48 fibrin sealant 48 ThermoGenesis 48 renal transplantation 48 Transfusion Medicine 48 EORTC 48 intravesical 48 dalbavancin 48 tacrolimus 48 factor G CSF 47 physiologically relevant 47 Cellular Therapy 47 endothelial progenitor cells 47 bioequivalence studies 47 Onalta 47 PolyHeme 47 Wyndgate 47 Androxal 47 DR Cysteamine 47 ex vivo 47 Secondary endpoints 47 rHuPH# 47 SparVax TM 47 registrational 47 Phase 1b trial 47 dobutamine 47 hematopoietic stem cell 47 OTCQX RHHBY 47 registrational trial